Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127690081 | 12769008 | 1 | I | 2013 | 20160809 | 20160921 | 20160921 | PER | US-ASTRAZENECA-2016SE86807 | ASTRAZENECA | 47.00 | YR | M | Y | 74.80000 | KG | 20160922 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127690081 | 12769008 | 1 | SS | ATENOLOL. | ATENOLOL | 1 | Oral | 54800 | MG | 0 | 50 | MG | QD | ||||||
| 127690081 | 12769008 | 2 | PS | SEROQUEL | QUETIAPINE FUMARATE | 1 | Oral | 109700 | MG | U | U | 20639 | 100 | MG | FILM-COATED TABLET | QD | |||
| 127690081 | 12769008 | 3 | SS | SEROQUEL | QUETIAPINE FUMARATE | 1 | Oral | 109700 | MG | U | U | 20639 | 100 | MG | FILM-COATED TABLET | QD | |||
| 127690081 | 12769008 | 4 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 0 | 2 | DF | QD | ||||||||
| 127690081 | 12769008 | 5 | C | BABY ASPIRIN | ASPIRIN | 1 | Oral | 81.0MG UNKNOWN | 0 | 81 | MG | ||||||||
| 127690081 | 12769008 | 6 | C | BABY ASPIRIN | ASPIRIN | 1 | Oral | 81.0MG UNKNOWN | 0 | 81 | MG | ||||||||
| 127690081 | 12769008 | 7 | C | BABY ASPIRIN | ASPIRIN | 1 | Oral | 81.0MG UNKNOWN | 0 | 81 | MG | ||||||||
| 127690081 | 12769008 | 8 | C | BUTRANS | BUPRENORPHINE | 1 | Transdermal | 0 | |||||||||||
| 127690081 | 12769008 | 9 | C | ANTIVERT | MECLIZINE HYDROCHLORIDE | 1 | Oral | 3 HALF PILLS AS NEEDED | 0 | ||||||||||
| 127690081 | 12769008 | 10 | C | BRONCHODILATOR | UNSPECIFIED INGREDIENT | 1 | Oral | 3 HALF PILLS AS NEEDED | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127690081 | 12769008 | 1 | Heart rate irregular |
| 127690081 | 12769008 | 2 | Sleep disorder |
| 127690081 | 12769008 | 3 | Sleep disorder |
| 127690081 | 12769008 | 4 | Nausea |
| 127690081 | 12769008 | 5 | Chest pain |
| 127690081 | 12769008 | 6 | Coronary artery disease |
| 127690081 | 12769008 | 7 | Myocardial infarction |
| 127690081 | 12769008 | 8 | Abdominal pain |
| 127690081 | 12769008 | 9 | Dizziness |
| 127690081 | 12769008 | 10 | Dizziness |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127690081 | 12769008 | Insomnia | |
| 127690081 | 12769008 | Intentional product misuse | |
| 127690081 | 12769008 | Off label use | |
| 127690081 | 12769008 | Product use issue | |
| 127690081 | 12769008 | Sleep apnoea syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127690081 | 12769008 | 1 | 2013 | 0 | ||
| 127690081 | 12769008 | 2 | 2013 | 2014 | 0 | |
| 127690081 | 12769008 | 3 | 2014 | 20160805 | 0 | |
| 127690081 | 12769008 | 5 | 2010 | 0 | ||
| 127690081 | 12769008 | 6 | 2010 | 0 | ||
| 127690081 | 12769008 | 7 | 2010 | 0 |